Directory

• Postdoctoral Researcher, National Institutes of Health, 2009 – 2011
• Postdoctoral Researcher, Stanford University, 2008 – 2009
• Ph.D., Brown University, 2008
• B.S., Nanjing University, 2003

• Athna Biotech, Inc., Founder, 2018 – present
• Journal of Nanobiotechnology, Associate Editor, 2019 – present

• 2020 Outstanding Editor Award, Journal of Nanobiotechnology
• Young Innovator Award in Nanobiotechnology by Nano Research, 2018
• NSF CAREER Award, 2016
• DoD Peer Reviewed Cancer Research Program  Idea Award, 2015
• Elsa U. Pardee Fellowship Award, 2014
• NIBIB Outstanding Researcher Award, 2011
• NIH Pathway to Independence Award (K99/R00) , 2010
• Travel Award, 2010 World Molecular Imaging Conference
• NRC NIH / NIST Fellowship (declined), 2009
• Travel Award, Society of Nuclear Medicine (SNM) Annual Meeting, 2009
• J. Nucl. Med. Best Basic Science Paper, 2009

The Xie Lab is interested in nanoparticle technologies. We engineer electrolyte-, polymer-, protein- and cell-based nanoplatforms that aim to solve unmet clinical needs. In particular, we are focused on developing novel nanotechnologies for cancer drug delivery, radiotherapy, imaging, and immunotherapy. Projects include salt nanoparticle therapeutics, X-ray induced photodynamic therapy, cell-based drug delivery, magnetic nanoparticle contrast agents, nanoparticle-based immunotherapy, and nanoparticle radiosensitizers.

• Nanotechnology
• Drug delivery
• Immunotherapy

Xie Research Lab